anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Title

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 303,780
Current window 231,991-232,020
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all
18 30 60

Component

231,991-232,020 of 303,780

filter-aware
28
The slide uses a timeline-based framework to contrast treatment options with clinical limitations.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
29
The slide uses a matrix-like structure to compare NVL-520's clinical profile against five competitors (Crizotinib, Entrectinib, Lorlatinib, Repotrectinib, Taletrectinib).Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
30
Slide presents three distinct preclinical data sets: IC50 viability assays, brain:plasma ratio, and selectivity index vs TRKB.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
31
The slide presents a summary of a clinical trial, including patient eligibility criteria and a breakdown of patient cohorts by dose level.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
32
Data presented in two tables: Patient Characteristics and Treatment History.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
33
Includes a summary table of ORR and a waterfall plot of tumor regression.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
34
Includes specific patient subgroup metrics (ORR, tumor shrinkage) and longitudinal imaging.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
35
Data as of 13 Sep 2022. Includes list of specific adverse events by grade.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
36
RP2D = Recommended Phase 2 Dose; QD = once daily; MTD = Maximum Tolerated Dose.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
40
The slide uses three distinct chart types to demonstrate the drug's efficacy and safety profile.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
41
The slide uses a timeline framework to connect current clinical program statuses to a future milestone.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
01
Slide 1
Includes company logo and date.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
04
The slide uses a circular photo of two professionals working together to humanize the corporate mission statement.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
05
The slide uses a circular process flow (Assess, Prescribe, Dispense, Administer) surrounding a central 'One Platform' concept.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · Solution1 hit
06
The slide uses a circular icon-grid layout to present a set of aspirational goals.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide highlights a specific publication in the AJHP as a standard reference.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Omnicell | Investor Presentation Deck | 27 slidesOmnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
Includes Central Pharmacy Dispensing Service (service portion), IV Compounding Service (service portion), EnlivenHealth solutions, Specialty Pharmacy Services, 340B solutions, Inventory Optimization Service, and other software solutions.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
11
The slide uses a visual comparison of bar charts to illustrate the difference in revenue recognition and cash flow timing between two business models.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
12
The slide uses a grouped bar chart to compare financial positions across two time periods.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
13
Includes footnotes defining backlog and long-term backlog criteria.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
14
Includes footnotes explaining specific revenue components.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
15
Omnicell | Investor Presentation Deck | 27 slidesOmnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
17
The strategy integrates ESG with Innovation as a core pillar.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
18
The slide uses a custom framework to map ESG pillars to foundational targets, risk management, and governance.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
19
The slide uses a 2x2 grid layout for the ESG pillars.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
20
Omnicell | Investor Presentation Deck | 27 slidesOmnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
21
Omnicell | Investor Presentation Deck | 27 slidesOmnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
22
Includes footnotes (a) and (b) explaining specific impairment and litigation costs.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
23
Includes footnotes (a), (b), and (c) detailing specific adjustments.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit